As clinical applications for genomics continue to increase, the US Food and Drug Administration (FDA) is collaborating across government, industry, and academia to inform regulatory science. In this session, learn how the FDA is using crowd-sourced science to contribute to significant advancements in the validation of variant calling technology, and hear how its precisionFDA multi-omics cloud environment leverages AWS and DNAnexus to connect data and tools to experts around the world.